FDA Approves Pfizer COVID-19 Vaccine For 5-11 Yo Children!

The US FDA has officially approved the Pfizer COVID-19 vaccine for use in 5-11 year-old children!

Here is what you need to know…

 

FDA Approves Pfizer COVID-19 Vaccine For 5-11 Yo Children!

On 29 October 2021, the US FDA officially approved the emergency use of the Pfizer-BioNTech COVID-19 vaccine in 5-11 year-old children.

This was based on their expert panel’s earlier approval, and their own evaluation of the data from Pfizer’s paediatric clinical trial.

Here is a short summary of the US FDA’s findings on the Pfizer-BioNTech vaccine for 5-11 year-old children :

Now that the FDA has approved the Pfizer-BioNTech vaccine for use in 5-11 year-old children, the US Centres for Disease Control and Prevention (CDC) will look into clinical recommendations for the vaccine.

I should point out that while the Pfizer paediatric vaccine is a lower-dose, improved version of the vaccine used in adults and adolescents.

Read more : Pfizer COVID-19 Vaccine For Kids : What You Need To Know!

 

FDA Excerpts On Pfizer Vaccine Approval For 5-11 Yo Children

Here is a selection of excerpts from the full FDA press release on their authorisation of the Pfizer-BioNTech vaccine for use in 5-11 year-old children.

Dose

The Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administered as a two-dose primary series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

Effectiveness

The immune responses of the younger age participants were comparable to the older participants. The vaccine was 90.7% effective in preventing COVID-19.

Safety

Commonly reported side effects in the clinical trial included injection site pain (sore arm), redness and swelling, fatigue, headache, muscle and/or joint pain, chills, fever, swollen lymph nodes, nausea and decreased appetite. More children reported side effects after the second dose than after the first dose. Side effects were generally mild to moderate in severity and occurred within two days after vaccination, and most went away within one to two days.

Stability + Storage

The FDA also authorized a manufacturing change for the vaccine to include a formulation that uses a different buffer; buffers help maintain a vaccine’s pH (a measure of how acidic or alkaline a solution is) and stability. This new formulation is more stable at refrigerated temperatures for longer periods of time, permitting greater flexibility for vaccination providers.

 

 

Recommended Reading

• Booster Dose Policy For COVID-19 Vaccine Explained!
• 5-11 Yo Children To Get Pfizer COVID-19 Vaccine Soon!
• Did Thai Student Die From Mixing Of COVID-19 Vaccines?
• Did Jean Yip Hairstylist Die From Vaccine Booster Dose?
• Are Top 4 COVID-19 Vaccines From China?
• Can Caffeine, Theophylline, Theobromine Prevent COVID-19?

 

Support Us!

If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!